Plethico Seeks Approval to Reset Convertible Bond Maturity Term

Plethico Pharmaceuticals Ltd. (PLEP), an Indian drugmaker, has sought approval from the central bank to reset terms of the $75 million convertible bonds that are due in October 2012, Chief Financial Officer Sanjay Pai said in a telephone interview from Mumbai.

To contact the reporter on this story: Anoop Agrawal in Mumbai at aagrawal8@bloomberg.net

To contact the editor responsible for this story: Ravil Shirodkar at rshirodkar@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.